Apellis Pharmaceuticals Inc
NASDAQ:APLS

Watchlist Manager
Apellis Pharmaceuticals Inc Logo
Apellis Pharmaceuticals Inc
NASDAQ:APLS
Watchlist
Price: 17.69 USD -0.39% Market Closed
Market Cap: 2.2B USD

EV/S
Enterprise Value to Sales

3
Current
18.7
Median
7.3
Industry
Lower than median
Lower than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S
3
=
Enterprise Value
2.3B USD
/
Revenue
775.8m USD

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/S
2.9
2-Years Forward
EV/S
2.4
3-Years Forward
EV/S
2